Does RITUXIMAB Cause Superficial vein thrombosis? 32 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Superficial vein thrombosis have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
32
Reports of Superficial vein thrombosis with RITUXIMAB
0.0%
of all RITUXIMAB reports
3
Deaths
23
Hospitalizations
How Dangerous Is Superficial vein thrombosis From RITUXIMAB?
Of the 32 reports, 3 (9.4%) resulted in death, 23 (71.9%) required hospitalization, and 1 (3.1%) were considered life-threatening.
Is Superficial vein thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Superficial vein thrombosis?
PREDNISONE (44)
UPADACITINIB (38)
CARBOPLATIN (37)
LENALIDOMIDE (32)
HUMAN IMMUNOGLOBULIN G (29)
IRON SUCROSE (22)
METHOTREXATE (22)
CANDESARTAN CILEXETIL (20)
CLOPIDOGREL BISULFATE (20)
ESOMEPRAZOLE (20)
Which RITUXIMAB Alternatives Have Lower Superficial vein thrombosis Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE